Developer of New Treatment for Severe Asthma Episodes Expects Phase 2 Clinical … – Benzinga

Developer of New Treatment for Severe Asthma Episodes Expects Phase 2 Clinical …
Benzinga
… the Founder, President and Chief Executive Officer of MediciNova, Inc. (NASDAQ: MNOV) tells investors about a promising treatment approach aimed at meeting the need for novel treatments for patients suffering from acute exacerbations of asthma, …

and more »